Piper Jaffray Initiates Coverage of Veracyte with Overweight Rating

Jun 20, 2014

|

NEW YORK (GenomeWeb) – Investment bank Piper Jaffray on Thursday initiated coverage of Veracyte with an overweight rating on the firm's stock and a $21 price target.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Recent Headlines from
Precision Oncology News

Patients, Advocates Urge FDA to Expedite Approval of ONC201 for Rare, Mutation-Defined Gliomas
Premium
Early Data Suggests Promising Efficacy of IL4-Targeted Toxin in Recurrent Glioblastoma
Premium
Kura Oncology Garners Promising Data for T-cell Lymphoma Drug in Biomarker-Defined Population
Premium
ASCO Studies Highlight Potential of Antibodies in Overcoming Anti-EGFR Rx Resistance in NSCLC
Premium
CDK4/6 Inhibitor Boosts Overall Survival in Advanced, Premenopausal Breast Cancer Subgroup
Premium

The Scan

A 'Double Whammy'

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

So Much Plastic

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

With a Little Lemon?

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

Science Has a Trio of Ruminant Genome Studies and More

In Science this week: three studies from the Ruminant Genome Project, and more.

Featured White Papers

BlueBee Data Security & Compliance

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

24

Featured Webinar

Comparison of Group B Streptococcus Molecular Assays for Routine Screening in Pregnant Women

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Jul

30

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu